Market revenue in 2023 | USD 2,044.6 million |
Market revenue in 2030 | USD 3,839.0 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Biocompatibility tests |
Fastest growing segment | Chemistry Test |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, Package Validation |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Sotera Health Co Ordinary Shares, Charles River Laboratories International Inc, NAMSA, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, TUV SUD, Element Materials Technology, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device testing services market will help companies and investors design strategic landscapes.
Biocompatibility tests was the largest segment with a revenue share of 50.38% in 2023. Horizon Databook has segmented the Canada medical device testing services market based on biocompatibility tests, chemistry test, microbiology & sterility testing, package validation covering the revenue growth of each sub-segment from 2018 to 2030.
Canada held a market share of 13.32% in North America in 2023. The country supports its medical device testing services landscape through outsourcing firms that cater to manufacturing and regulatory compliance needs of medical device manufacturers, thereby leading to increasing outsourcing activity in the region.
In addition, the presence of a well-established healthcare system and favorable government support are expected to improve the number of medical device services in the country. Furthermore, in the country, class I medical devices are prominently outsourced due to lower risk, and higher utility, which increases the requirement for medical device testing services.
For instance, diagnostic tools and their components, such as X-ray scanners, are class I products that can be outsourced by clinical partners for the analysis of material characterization, product shelf-life, and stability testing, among others.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada medical device testing services market , including forecasts for subscribers. This country databook contains high-level insights into Canada medical device testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account